Anabio R&D

slider-home-1903×640

For The Future

Without Antibiotics

We are together

slider-home-02

Assume Responsibility For

A Highest Quality Products

We commit to observe the modern technologies and advanced research equipment to

Home 1

ABOUT US

We are together For The Future Without Antibiotics

From the fact that “Antibiotic resistance – The pain of humanity”, ANABIO R&D is constantly striving to find, research and develop the new products that apply Spore Probiotic Technology to protect and improve human health comprehensively, naturally and effectively.

Commits to use the modern technologies
Commits to use advanced research equipment
Ensure products are created with the best quality
Desire to take care of health for every person in a safe and sustainable way

Call for any questions

0242 2253211

sign-02

Dr. Nguyen Hoa Anh,

Director ANABIO R&D

Spobio Center

Spobiotic Research Center (Spobio Center)

The Spobiotic Research Center is equipped with many modern machines and equipment for in-depth researches on spore probiotics using techniques of microbiology, biophysics, biochemistry, molecullar and cellular biology

About Us

Overall Introduction

Spobiotic Research Center (Spobio Center) was established on May 18th, 2022. Spobio Center comes out into society with the aim of building an in-depth research center on spore probiotics and will be the driving force for more scientists around the world to be interested in and develop spore probiotics as a possible solution for a future without antibiotics

09 +

International publications

15 +

National publications

12 +

Conference reports

05 +

Patent registration

08 ₊

Trademark registration

What we do

The Prominent Studies

We are aware that product is the foundation of business. We make efforts ceaselessly in research and development of products that apply spore probiotics technology to protect anf improve human health comprehensively

Study on application of LiveSpo® Navax in the supportive treatment of acute rhinosinusitis and chronic purulent otitis media

Assessment of acute and sub-acute toxicity of two products for gastrointestinal tract LiveSpo® COLON (an other name LiveSpo® Colytis) and LiveSpo® OVAX (an other name LiveSpo® Ovax Kids)

Blind, randomized and controlled clinical trial for evaluation of safety and efficacy of LiveSpo® COLON in supportive treatment of colitis in combination with the routine treatment regimen

Assessment of acute and sub-acute toxicity in oral administration, eyes irritation test, nose irritation test and mucosa irritation test of LiveSpo® NAVAX

Study on application of LiveSpo® Navax in treatment of Acute Respiratory Tract Infections due to RSV (Respiratory syncytial virus) and influenza virus

OUR NEWS

Recent Articles And News

admin November 29, 2024November 29, 2024

R&D Team and LiveSpo Pharma Make Their Mark at VNU DEC 2024 with Breakthrough Dental Solutions

The Spobiotic Research Center (Spobio Center), ANABIO R&D participated in the Dental Exhibition & Cong...

admin November 14, 2024November 14, 2024

APPLICATION OF PROBIOTICS LiveSpo® CLAUSY AND LiveSpo® DIA30 IN TREATING PERSISTENT DIARRHEA IN CHILDREN – THE 25th NATIONAL PEDIATRICS CONFERENCE

From October 31st to November 2nd, 2024, the Spobiotic Research Center, ANABIO R&D, participated in the 25...

admin November 6, 2024November 6, 2024

PIONEERING STUDY ON NASAL SPRAY PROBIOTICS (LIVESPO® NAVAX): A BREAKTHROUGH IN PREVENTING RESPIRATORY INFECTIONS IN CHILDREN

Recently, the Spobiotic Research Center collaborated with Hanoi Medical University to conduct the study titled...

admin November 5, 2024November 5, 2024

LIVESPO® NAVAX: A BREAKTHROUGH PRODUCT IN PREVENTING RESPIRATORY DISEASES IN CHILDREN, REPORTED AT THE 27TH NATIONAL SCIENTIFIC CONFERENCE ON OTOLARYNGOLOGY & HEAD AND NECK SURGERY

Four staff members from the Spobio Research Center, ANABIO R&D Ltd, represented the company at the 27th Na...

RESEARCH COOPERATION

Cooperation Units

Hosted By Wordpress Clusters